Privia Health's (PRVA) Guidance Keeps Rising, So Is The Stock Keeping Pace?
Privia Health (NASDAQ:PRVA) just turned in a quarter that checked every box management set for itself, and then raised the bar again for the rest of the year.
Privia Health Group Inc. (PRVA)
Market is closed
Sector: Services-Health Services
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Royce & Associates Chuck Royce | 745,948 | $14,687,716 | -10% | 0.13% |
| 2. | Renaissance Technologies Jim Simons | 613,300 | $12,075,877 | -4% | 0.02% |
| 3. | Squarepoint Ops LLC Maxime Fortin (Cio) | 387,744 | $7,634,679 | +96% | 0.01% |
| 4. | Quantinno Capital Hoon Kim | 170,396 | $3,355,097 | +69% | 0% |
| 5. | Rhenman & Partners Asset Management Henrik Rhenman | 66,000 | $1,299,540 | +32% | 0.14% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $16.50 | 364 | $6,006.00 | 5,773,522 | 2024-06-11 | Filing | |
| $16.50 | 5,306 | $87,549.00 | 5,773,158 | 2024-05-29 | Filing | |
| $16.49 | 4,280 | $70,577.20 | 5,767,852 | 2024-05-24 | Filing | |
| $16.37 | 10,000 | $163,700.00 | 52,611 | 2024-05-23 | Filing | |
| $16.28 | 172,642 | $2,810,611.76 | 5,763,572 | 2024-05-23 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $27.67 | 21,275 | $588,679.25 | 164,853 | 2026-07-09 | Filing | |
| $27.57 | 600 | $16,542.00 | 186,128 | 2026-07-07 | Filing | |
| $27.24 | 53,722 | $1,463,387.28 | 68,188 | 2026-07-06 | Filing | |
| $27.33 | 59,037 | $1,613,481.21 | 76,651 | 2026-07-02 | Filing | |
| $27.50 | 24,734 | $680,185.00 | 186,728 | 2026-07-02 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 6,830,627 | $134,495,036 | 0.01% | |
| 2. | 5,145,089 | $101,306,802 | 0% | |
| 3. | 3,203,089 | $63,081,459 | 0% | |
| 4. | 2,895,288 | $57,008,213 | 1.67% | |
| 5. | 2,780,710 | $54,752,182 | 0.01% |
News See All
Privia Health Group, Inc. (NASDAQ:PRVA) Q1 2026 Earnings Call Transcript
Privia Health Group, Inc. (NASDAQ:PRVA) Q1 2026 Earnings Call Transcript May 8, 2026 Operator: Hello, and thank you for standing by.
8 Best Mid-Cap Growth Stocks to Invest In
In this article, we will take a look at some of the best mid-cap growth stocks that currently yield attractive upside potential for investors.
Privia Health Group, Inc. (NASDAQ:PRVA) Q4 2025 Earnings Call Transcript
Privia Health Group, Inc. (NASDAQ:PRVA) Q4 2025 Earnings Call Transcript February 26, 2026Privia Health Group, Inc. beats earnings expectations. Reported EPS is $0.07, expectations were $0.04.
Privia Health Group, Inc. (PRVA): A Bull Case Theory
We came across a bullish thesis on Privia Health Group, Inc. on LongTermValue Research’s Substack. In this article, we will summarize the bulls’ thesis on PRVA.
Privia Health Group, Inc. (NASDAQ:PRVA) Q3 2025 Earnings Call Transcript
Privia Health Group, Inc. (NASDAQ:PRVA) Q3 2025 Earnings Call Transcript November 6, 2025Privia Health Group, Inc. misses on earnings expectations. Reported EPS is $0.05 EPS, expectations were $0.06.
Privia Health Group, Inc. (NASDAQ:PRVA) Q2 2025 Earnings Call Transcript
Privia Health Group, Inc. (NASDAQ:PRVA) Q2 2025 Earnings Call Transcript August 7, 2025Privia Health Group, Inc. misses on earnings expectations. Reported EPS is $0.02 EPS, expectations were $0.05.
Privia Health Group, Inc. (PRVA) Earns Top Pick Status from TD Cowen
Privia Health Group, Inc. (NASDAQ:PRVA) is among the best NASDAQ stocks under $50 to buy. Analysts at TD Cowen have named Privia Health Group, Inc.
10 Best NASDAQ Stocks Under $50 to Buy
In this article, we will take a look at some of the best NASDAQ stocks under $50 to buy.
Barclays Raises Privia Health (PRVA) PT to $24 on Strong Q1 Fee-for-Service Performance
On Tuesday, Barclays analyst Andrew Mok increased the price target on Privia Health Group Inc. (NASDAQ:PRVA) to $24 from $23, while maintaining an Equal Weight rating on the shares.
Hedge Fund Resource Center